Modulation of fast excitatory synaptic transmission by cyclothiazide and GYKI 52466 in the rat hippocampus
- 4 July 1994
- journal article
- Published by Elsevier in Neuroscience Letters
- Vol. 175 (1-2) , 21-24
- https://doi.org/10.1016/0304-3940(94)91068-5
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Comparative patch clamp studies on the kinetics and selectivity of glutamate receptor antagonism by 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) and 1-(4-amino-phenyl)-4-methyl-7,8-methylendioxyl-5H-2,3-benzodiazepine (GYKI 52466)Neuropharmacology, 1994
- Effects of cyclothiazide on synaptic responses in slices of adult and neonatal rat hippocampusNeuroReport, 1994
- Treatment with an AMPA Antagonist 12 Hours following Severe Normothermic Forebrain Ischemia Prevents CA1 Neuronal InjuryJournal of Cerebral Blood Flow & Metabolism, 1993
- Anticonvulsant activity of AMPA/kainate antagonists: comparison of GYKI 52466 and NBQX in maximal electroshock and chemoconvulsant seizure modelsEpilepsy Research, 1993
- Desensitization of AMPA receptors upon multiquantal neurotransmitter releaseNeuron, 1993
- A benzodiazepine recognition site associated with the non-NMDA glutamate receptorNeuron, 1993
- GYKI 52466, a 2,3-benzodiazepine, is a highly selective, noncompetitive antagonist of AMPA/kainate receptor responsesNeuron, 1993
- Activation and desensitization of glutamate-activated channels mediating fast excitatory synaptic currents in the visual cortexNeuron, 1992
- The Time Course of Glutamate in the Synaptic CleftScience, 1992
- 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a Neuroprotectant for Cerebral IschemiaScience, 1990